Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.49101.47-45.3620.0567.42

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is 11.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202511.49
Mar2024101.47
Mar2023-45.36
Mar202220.05
Mar202167.42

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 11.49
-88.68
Mar2024 101.47
Positive
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,656.7 Cr 0.2% -4.5% -37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,471.0 Cr 0.3% 4.1% -9.9% Stock Analytics
DIVIS LABORATORIES ₹172,294.0 Cr -1.7% 8.5% 13.2% Stock Analytics
CIPLA ₹127,946.0 Cr -3.4% 3% 4.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,691.0 Cr 0.7% -0.5% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹107,214.0 Cr 0.2% -1.1% -3.6% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

0.2%

-4.5%

-37%

SENSEX

1%

3.3%

4.5%


You may also like the below Video Courses